SU505358A3 - The method of producing piperazine derivatives - Google Patents

The method of producing piperazine derivatives

Info

Publication number
SU505358A3
SU505358A3 SU1970167A SU1970167A SU505358A3 SU 505358 A3 SU505358 A3 SU 505358A3 SU 1970167 A SU1970167 A SU 1970167A SU 1970167 A SU1970167 A SU 1970167A SU 505358 A3 SU505358 A3 SU 505358A3
Authority
SU
USSR - Soviet Union
Prior art keywords
ethanol
chloride
piperazine derivatives
lower alkyl
methylphenyl
Prior art date
Application number
SU1970167A
Other languages
Russian (ru)
Inventor
Ментруп Антон
Рент Эрнст-Отто
Шромм Курт
Даннеберг Петер
Original Assignee
К.Х.Берингер Зон (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by К.Х.Берингер Зон (Фирма) filed Critical К.Х.Берингер Зон (Фирма)
Application granted granted Critical
Publication of SU505358A3 publication Critical patent/SU505358A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Description

Изобретение относитс  к способу получени  новых производных пиперазина, которые обладают биологической активностью и могут найти применение, например, в медицине . Известен в органической химии способ получени  простых эфиров, например, путем алкйлировани  соответствующих спиртов. В качестве алкилируюших с агентов используют алкилгалогенид или диапкильсульфат или эфир N -толуолсульфоновой кислоты. Описываетс  основанный на известной в органической химии реакции способ получени  производных пиперазина общей формулы -/ , OR- где 1 - низший алкил; N - низший алкилкарбамоил, низший алкил; д - атом водорода, низший алкил. или их солей, заключаюшиис  в, том, оединение обшей формулы О 5 имеет вышеуказанные значени ; обрабатывают соответствующим алкилирующим или ацилирующим. агенто м с последующим выделением целевого продукта известным приемом в виде основани  или соли . В качестве алкилирующего средства используют обычно низший .алкилгалогенид, ди( низший)-алкилсульфат, сложный эфир сульфоновой кислоты в присутствии щелочи. Также можно сначала ОН-пруппу заменить атомом хлора с помощью хлорирующего SOCl, и засредства , как РС1 или о тем полученное соединение подвергать взаимодействию с щелочным алкогол том. Вве- дение ацильной группы осуществл ют по- cjioncTiJOM соогветствующего ацилирующего средства, например хлорангидрида кислоты, карбамоилхлорида, ангидрица. Пример. 1-Г1- 4-имидазолидинон- ( 2) -илфенил -Х-ацетилоксиэтил -4- (2-метипфенил -пиперазин или его хлорид 7,6 г (О,О2 моль) 1-|1- 4-амидазолидинон-{2 )-илфeнил -l-гидpooкcиэтилl-4- (2-мeтилфeнил)-пипepaзинa, 2,5 мл ацетангидрида и 76 мл хлороформа в течеЕше 2 час кип т т с обратным холодильником . После отгонки растворител  кристаллизованный этанолом остаток раствор ют в хлороформе и экстрагируют путем встр хивани  с раствором карбоната кали  и водои . Органическую фазу сушат сульфатом натри  и хлороформ отгон ют. Полученный остаток кристаллизуют в этаноле. Из ос-, новани  в гор чем этаноле после добавки концентрированной сол ной кислоты получают хлорид. Соль после пере11;ристаллизации из этанола имеет т. пл. 31О С (разложение). Выход составл ет 5,5 г. П р и м е р 2. 1-Г1- 4-им1щазолидино н-( 2) -илфе нил -1 - мети карбамоилоксиэтилТ .-4-(2-метилфенил)-Ггиперазин или его хлорид. 7,6 г (0,02 моль) 1-| 1- 4-имидазолидинон- ( 2)-илфенил) -1-гиароксиэтил -4- -(2-метилфенил)-пиперазина, 1,1 мл метил изоцианата и 114 мл хлороформа а. течение 1 час при 60-70°С встр хивают в монтежю . После отгонки хлороформа остаетс  остаток, который кристаллизуют в этаноле. Из основани  в гор чем этаноле путем добавки этанольной сол ной кислоты получают хлорид. Соль после . перекристаллизации из этанола имеет т. пл. (разложение ). Выход составл ет7,5 г. П р и м е р 3. 1-Г1- 4-имидазолидинон- ( 2) -илфенил -1-этоксиэтил1.-4-( 2-метилфенил ) -пиперазин. К раствору из 1,84 г (0,08 моль) натри  в 200 мл абсолютного этанола добавл ют 8,7 г (О,О2 моль) хлорид l-Jl- |4 имидазолидинон-(2)-клфенкл -1-х 3THnJ-4- (2-метилфенил) -липеразина, получе КЗ соотьетствуюшего гидроксмсоединеи посредством -хлорировани  с РС1 в ацето нитриле. После перемешивани  в течение 1 час при 40 С добавл ют рассчитанное количество этанольной сол ной кислоты, отсасывают от осажденногоNaCl и этанол отгон ют, оставл   лишь 20 мл. Из остатка получают основание. Основание в этаноле с рассчитанным количеством ме- тансульфоновой кислоты дает метансульфонат вышеуказанного соединени . Аналогичн следующие соедиH/A-N S-H ВгС-СНг -сн-/А.кх%.„ о гС -СН, /- и HHf УИ--Ч „ I I п «2С-сн, H-Q K -N-H н,с -сн. H HjC-CH, Of VH This invention relates to a process for the preparation of new piperazine derivatives which possess biological activity and can be used, for example, in medicine. A method of producing ethers is known in organic chemistry, for example, by alkylation of the corresponding alcohols. Alkylating agents used are alkyl halide or diphosphate or N-toluenesulfonic acid ester. Describes a method for the preparation of piperazine derivatives of the general formula, based on the reaction known in organic chemistry, where OR is lower alkyl; N is lower alkylcarbamoyl, lower alkyl; d - hydrogen atom, lower alkyl. or their salts, concluding that the compound of the general formula O 5 is as defined above; process the corresponding alkylating or acylating. agents, followed by isolation of the desired product by a known technique in the form of a base or salt. As an alkylating agent, usually the lower alkyl halide, di (lower) alkyl sulfate, sulfonic acid ester in the presence of alkali are used. It is also possible to first replace the OH-group with a chlorine atom with the aid of chlorinating SOCl, and using an agent such as PC1 or the resulting compound, to react with an alkaline alcohol. The introduction of the acyl group is carried out by means of a suitable acylating agent, for example, an acid chloride, carbamoyl chloride, anhydrite. Example. 1-H1-4-imidazolidinon- (2) -ylphenyl-X-acetyloxyethyl-4- (2-methylphenyl-piperazine or its chloride 7.6 g (O, O2 mol) 1- | 1-4-amidazolidinone- {2 ) -ylphenyl-l-hydroxyethyl-4- (2-methylphenyl) -piperazine, 2.5 ml of acetic anhydride and 76 ml of chloroform for more than 2 hours and refluxed. After distilling off the solvent, the residue crystallized with ethanol was dissolved in chloroform and extracted by shaking with a solution of potassium carbonate and water. The organic phase is dried with sodium sulfate and the chloroform is distilled off. The residue obtained is crystallized in ethanol. Chloride is obtained from the base in hot ethanol after addition of concentrated hydrochloric acid. Salt after re; 11 installation from ethanol has so pl. 31О С (decomposition). The yield is 5.5 g. EXAMPLE 2 1-G1-4-im1chazolidino n- (2) -ylphenyl -1-methy carbamoyloxyethylT.-4- (2-methylphenyl) -hyperazine or its chloride . 7.6 g (0.02 mol) 1- | 1- 4-imidazolidinone- (2) -ylphenyl) -1-hydroxyethyl-4- - (2-methylphenyl) -piperazine, 1.1 ml of methyl isocyanate and 114 ml of chloroform a. for 1 hour at 60-70 ° C, shake into a montage. After the distillation of chloroform, a residue remains which is crystallized in ethanol. Chloride is obtained from the base in hot ethanol by the addition of ethanolic hydrochloric acid. Salt after. recrystallization from ethanol has an mp. (decomposition ). The yield is 7.5 g. EXAMPLE 3. 1-G1-4-imidazolidinone- (2) -ylphenyl -1-ethoxyethyl 1.-4- (2-methylphenyl) piperazine. To a solution of 1.84 g (0.08 mol) of sodium in 200 ml of absolute ethanol was added 8.7 g (O, O2 mol) chloride l-Jl- | 4 imidazolidinon- (2) -klfenkl -1-x 3THnJ -4- (2-methylphenyl) -liperazine, resulting in a short-circuit of the corresponding hydroxy compound by -chlorination with PC1 in acetonitrile. After stirring for 1 hour at 40 ° C, the calculated amount of ethanolic hydrochloric acid is added, sucked off from precipitated NaCl and the ethanol is distilled off, leaving only 20 ml. A base is obtained from the residue. A base in ethanol with a calculated amount of methanesulfonic acid gives the methanesulfonate of the above compound. Similarly, the following compounds / A-N S-H BgC-SNg-Sn- / A. x%. „About gC -CH, / - and HHf UI - H„ I I n “2C-sn, H-Q K -N-H n, s-сн. H HC-CH, Of VH

f O-CHrCH/-V/%f O-CHrCH / -V /%

00

HtC -CHiHtC -CHi

1one

0 Д0 D

,-CH,-CH,-CHHQK/ VH, -CH, -CH, -CHHQK / VH

HjC-CH,HjC-CH,

СН-СН.-КCH-CH.-K

OROR

где К - низший алкил; where K is lower alkyl;

м - низший алкилкарбамоил, низшийm - lower alkylcarbamoyl, lower

ацил; К., - атом водорода, низший алкил,acyl; K. - hydrogen atom, lower alkyl,

или их солей, отличающийс тем, что соединение общей формулыor salts thereof, characterized in that the compound of the general formula

Wl-CH,Wl-CH,

CHCH

П -1 ГЛ4н-сн-/P -1 GL4n-sn- /

сульфат 1-|1- 4-имидазолидинон-(2)илфенилЗ-1-н .- утилкарбамоилоксиэтил -4- (2-метилфенйл)-Пйг(еразина; т, пл. 127°С (разложение).1- | 1-4-imidazolidinone- (2) ylphenylZ-1-n. utilcarbamoyloxyethyl-4- (2-methylphenyl) -Pig (naphazine; t, pl. 127 ° C (decomposition).

формула изобретени invention formula

Claims (4)

1. Способ получени  производных пипе- разина общей формулы1. A method for producing piperasin derivatives of the general formula Н.СN.S. имеет вышеуказанное значение,has the above meaning обрабатывают соответствующим алкилирующим или ацилирующим агентом с последующим выделением целевого продукта известным приемом в виде основани  или соли;treat with an appropriate alkylating or acylating agent followed by isolation of the target product by a known technique as a base or salt; 2. Способ по п. 1, о т л и ч а ю щ и йс   тем, что в качестве алкилирующего агента используют соответствующий низший алкилгалогенид, ди(низщий)-алкилсульфат, сложный эфир сульфоновой кислоты.2. The method according to p. 1, about tl and h and y and that with the use of the corresponding lower alkyl halide, di (lower) alkyl sulfate, sulfonic ester ester as the alkylating agent. 3. Способ по пп. Д и 2, о т л и ч а юш и и с   тем, что реакцию осуществл ют в присутствии щелочи. 3. The method according to paragraphs. D and 2, that is, that the reaction is carried out in the presence of alkali. 4. Способ по п. 1, о т л и ч а ю щ и йс   тем, что в качестве ацилирующего агента используют хлоранГидрид кислоты, карбамоилхлорид .4. The method according to claim 1, of which is tl and h and yc in that the acid chloride, carbamoyl chloride is used as the acylating agent.
SU1970167A 1971-06-07 1973-11-14 The method of producing piperazine derivatives SU505358A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT492071A AT311956B (en) 1971-06-07 1971-06-07 Process for the preparation of new phenylimidazolidinone derivatives and their salts

Publications (1)

Publication Number Publication Date
SU505358A3 true SU505358A3 (en) 1976-02-28

Family

ID=3569889

Family Applications (8)

Application Number Title Priority Date Filing Date
SU1791532A SU453839A3 (en) 1971-06-07 1972-05-31 METHOD OF OBTAINING PHENYLIMIDAZOLIDINONES
SU1970169A SU493067A3 (en) 1971-06-07 1972-05-31 The method of obtaining phenylimidazolidinone
SU1970242A SU509228A3 (en) 1971-06-07 1973-11-14 The method of obtaining derivatives of piperazine
SU1970170A SU498907A3 (en) 1971-06-07 1973-11-14 The method of obtaining phenylimidazolidinone
SU1970167A SU505358A3 (en) 1971-06-07 1973-11-14 The method of producing piperazine derivatives
SU1970168A SU503516A3 (en) 1971-06-07 1973-11-14 The method of producing piperazine derivatives
SU1970171A SU492085A3 (en) 1971-06-07 1973-11-14 The method of obtaining phenylimidazolidinone
SU1970164A SU499806A3 (en) 1971-06-07 1973-11-14 The method of producing piperazine derivatives

Family Applications Before (4)

Application Number Title Priority Date Filing Date
SU1791532A SU453839A3 (en) 1971-06-07 1972-05-31 METHOD OF OBTAINING PHENYLIMIDAZOLIDINONES
SU1970169A SU493067A3 (en) 1971-06-07 1972-05-31 The method of obtaining phenylimidazolidinone
SU1970242A SU509228A3 (en) 1971-06-07 1973-11-14 The method of obtaining derivatives of piperazine
SU1970170A SU498907A3 (en) 1971-06-07 1973-11-14 The method of obtaining phenylimidazolidinone

Family Applications After (3)

Application Number Title Priority Date Filing Date
SU1970168A SU503516A3 (en) 1971-06-07 1973-11-14 The method of producing piperazine derivatives
SU1970171A SU492085A3 (en) 1971-06-07 1973-11-14 The method of obtaining phenylimidazolidinone
SU1970164A SU499806A3 (en) 1971-06-07 1973-11-14 The method of producing piperazine derivatives

Country Status (20)

Country Link
AR (7) AR200112A1 (en)
AT (1) AT311956B (en)
AU (1) AU473287B2 (en)
BE (1) BE784475A (en)
BG (1) BG22822A3 (en)
CA (1) CA1011336A (en)
CH (7) CH573425A5 (en)
DD (1) DD101403A5 (en)
DE (1) DE2223751A1 (en)
ES (1) ES403542A1 (en)
FR (1) FR2140492B1 (en)
GB (1) GB1391491A (en)
HU (1) HU165493B (en)
IE (1) IE37812B1 (en)
IL (1) IL39620A (en)
NL (1) NL7207701A (en)
NO (1) NO136841C (en)
SE (1) SE392902B (en)
SU (8) SU453839A3 (en)
ZA (1) ZA723840B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822678A1 (en) * 1998-05-20 1999-11-25 Bayer Ag New 1,3-diaza-2-oxo-cycloalkane derivatives, useful as pre- or post-emergence, total or selective herbicides
CA2568609A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
WO2004106291A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
RU2497810C1 (en) * 2012-06-28 2013-11-10 Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" Method of obtaining n,n-diaryl-substituted 2-trichloromethyl-imidazolidines

Also Published As

Publication number Publication date
NO136841C (en) 1977-11-16
AT311956B (en) 1973-12-10
SU498907A3 (en) 1976-01-05
IL39620A (en) 1977-02-28
AR203017A1 (en) 1975-08-08
CH589645A5 (en) 1977-07-15
ES403542A1 (en) 1975-05-01
CH589646A5 (en) 1977-07-15
NO136841B (en) 1977-08-08
AR207109A1 (en) 1976-09-15
HU165493B (en) 1974-09-28
SU493067A3 (en) 1975-11-25
CH583729A5 (en) 1977-01-14
AR200112A1 (en) 1974-10-24
CH591475A5 (en) 1977-09-15
SE392902B (en) 1977-04-25
SU503516A3 (en) 1976-02-15
AU4312972A (en) 1973-12-13
CH573425A5 (en) 1976-03-15
AR200139A1 (en) 1974-10-24
SU509228A3 (en) 1976-03-30
CH589644A5 (en) 1977-07-15
BE784475A (en) 1972-12-06
AR205522A1 (en) 1976-05-14
DD101403A5 (en) 1973-11-05
IL39620A0 (en) 1972-08-30
AR202903A1 (en) 1975-07-31
IE37812L (en) 1972-12-07
SU499806A3 (en) 1976-01-15
SU453839A3 (en) 1974-12-15
CH590269A5 (en) 1977-07-29
DE2223751A1 (en) 1972-12-28
GB1391491A (en) 1975-04-23
IE37812B1 (en) 1977-10-26
ZA723840B (en) 1974-02-27
SU492085A3 (en) 1975-11-15
FR2140492A1 (en) 1973-01-19
CA1011336A (en) 1977-05-31
AR202904A1 (en) 1975-07-31
BG22822A3 (en) 1977-04-20
AU473287B2 (en) 1973-12-13
NL7207701A (en) 1972-12-11
FR2140492B1 (en) 1976-03-05

Similar Documents

Publication Publication Date Title
SU552025A3 (en) Method for preparing phenyl-imidazolyl alkane derivatives
DK159680B (en) CYCLIC IMIDES USED FOR THE PREPARATION OF CYCLIC AMINO ACIDS
US2734904A (en) Xcxnhxc-nh
SU578870A3 (en) Method of preparing n-(methoxymethyl)furilmethyl-6,7-benzomorphanes or morhinanes or their salts
SU574146A3 (en) Method of preparing substituted derivatives of hydrazides of a-amino-oxycarboxylic acids or salts thereof
SU575026A3 (en) Method of preparing 2,6-disubstituted 2-phenyliminoimidazolidines or salts thereof
SU505358A3 (en) The method of producing piperazine derivatives
SU453836A3 (en) Method of producing 3-benzylpyridine derivatives or their salts
DE1945542A1 (en) Process for the preparation of 4-heterosubstituted azetidinones- (2)
FI59086C (en) FOERFARANDE FOER FRAMSTAELLNING AV 2,5-DISUBSTITUERADE BENSAMIDER
US3043868A (en) N-xenylalkanoylaminoalkanoic acids and esters thereof
SU541429A3 (en) The method of obtaining derivatives of 3-alkyl-4-sulfamoylaniline or their salts
SU481153A3 (en) The method of obtaining cyanophenoxyacetonitriles
SU795487A3 (en) Method of preparing hellebrigenic derivatives or their salts
SU862822A3 (en) Method of preparing n-cyano-n'-methyl-n"-/2-((4-methyl-5-imidazolyl)-methylthio)-ethyl/-guanidine
US2517496A (en) Preparation of symmetrical monoaminodihydroxytoluene
JPS5822107B2 (en) α↓-aminomethylene↓-β↓-formylaminopropionitrile and its production method
SU470957A3 (en) The method of obtaining 4-aminopyrrolin-3-one-2 derivatives or their salts
SU1118286A3 (en) Method of obtaining n-cyano-n'-methyl-n"-(2-mercapto-ethyl)-guanidine
FI59793B (en) MELLAN PRODUCTS FOR FRAMSTATION PROCESSING OF HETEROCYCLIC BENZAMIDES WITH PHARMACOLOGICAL ACTIVITIES AND FOR PHARMACEUTICAL FRAMSTATION OF MELLAN PRODUCTS
SU458130A3 (en) The method of obtaining nitrofurylpyriidine derivatives
US2530570A (en) Pyrimidylmercapto-carboxylic acids
SU430554A1 (en) Method of producing 2,3-benzoxazepine derivatives
SU501668A3 (en) The method of obtaining derivatives of 2-aminobenzylamine
SU523090A1 (en) The method of obtaining quinazoline derivatives